report banner

PHI News Room

All News and Press Releases

PostNews: Interim Report
A pen and a calculator placed on top of papers with charts.

Interim Report 3 2024/25

Sales grew significantly for both Q3 and YTD, outperforming the FY results of the previous year. Gross margin continues to be strong, even slightly above planned levels (+4pp). Overall costs remain stable and as per plan, with higher administrative costs due to the capital raise offset by lower R&D expenses. The absolute key to transforming the Company, both short-term and long-term, is a significant increase in sales, which is expected due to a strong pipeline and company potential.
PostNews: Press Release

Phase Holographic Imaging Announces Next Generation HoloMonitor

Phase Holographic Imaging (PHI) is pleased to announce that the next generation of PHI’s live cell imaging system enters its final development stage. The new model is currently undergoing pre-production testing both internally and externally at the Huntsman Cancer Institute and Wake Forest Institute of Regenerative Medicine.
PostNews: Press Release
Phase Holographic Imaging logotype

Phase Holographic Imaging Announces Management Changes

Recent technical progress has led the Board of Directors of Phase Holographic Imaging (PHI) to decide to focus resources on the company’s clinical product development program. In relation to this, the Board of Directors has, in discussion with CEO Anders Månsson, decided to initiate the search for a new CEO to lead the ambitious development that lies ahead.
PostNews: Press Release

PHI announces last day of trading in BTA

PostNews: Press Release

Bulletin from the annual general meeting of Phase Holographic Imaging PHI AB (publ) 8 January 2025

Phase Holographic Imaging PHI AB (publ), held a general meeting on 8 January 2025. The following resolutions were made.
PostNews: Press Release

PHI announces outcome of rights issue

123442

Company News

News in Swedish